Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/10/24
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 02/23/23
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 10/24/22
End: 10/24/29
Due: 10/24/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma | NCT06087341 | Antonio Pérez Martínez | user2@example.com | None | 2024-01-10 | 2028-04-30 | 2029-04-30 | - | - | 2025-07-14 |
| Technological Gaming in Cancer Survivors (WINNERS) | NCT06312969 | Antonio Pérez Martínez | user2@example.com | None | 2023-02-23 | 2025-02-28 | 2026-02-28 | - | - | 2025-07-14 |
| Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas | NCT05952310 | Antonio Pérez Martínez | user2@example.com | None | 2022-10-24 | 2029-10-24 | 2030-10-24 | - | - | 2025-07-14 |